Zealand Pharma A/S
CSE:ZEAL

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
CSE:ZEAL
Watchlist
Price: 720 DKK -1.1% Market Closed
Market Cap: 50.9B DKK
Have any thoughts about
Zealand Pharma A/S?
Write Note

Balance Sheet

Balance Sheet Decomposition
Zealand Pharma A/S

Current Assets 8.7B
Cash & Short-Term Investments 8.5B
Receivables 245.5m
Other Current Assets 803k
Non-Current Assets 911.4m
Long-Term Investments 746.1m
PP&E 128.9m
Intangibles 11.6m
Other Non-Current Assets 24.8m
Current Liabilities 245.6m
Accounts Payable 229.7m
Other Current Liabilities 15.9m
Non-Current Liabilities 501.1m
Long-Term Debt 373.6m
Other Non-Current Liabilities 127.5m

Balance Sheet
Zealand Pharma A/S

Rotate your device to view
Balance Sheet
Currency: DKK
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
538
419
323
589
861
1 081
960
1 129
1 069
449
Cash Equivalents
538
419
323
589
861
1 081
960
1 129
1 069
449
Short-Term Investments
0
0
0
75
299
299
297
299
109
1 184
Total Receivables
35
174
22
16
8
16
62
110
83
111
Accounts Receivables
25
158
12
6
3
1
46
73
1
1
Other Receivables
10
16
11
10
5
15
15
37
81
110
Inventory
0
0
0
0
0
0
65
118
1
8
Other Current Assets
2
24
27
7
12
31
35
65
54
28
Total Current Assets
575
617
373
687
1 179
1 427
1 420
1 722
1 316
1 780
PP&E Net
19
16
14
16
16
125
213
221
165
150
PP&E Gross
19
16
14
16
16
125
213
221
165
150
Accumulated Depreciation
63
70
48
53
56
58
53
69
71
70
Intangible Assets
0
0
0
0
0
2
57
54
0
12
Note Receivable
0
0
0
0
0
0
1
1
18
16
Long-Term Investments
0
0
0
9
33
36
32
27
38
21
Other Long-Term Assets
3
3
308
9
3
9
38
43
2
1
Total Assets
597
N/A
636
+7%
695
+9%
721
+4%
1 230
+71%
1 600
+30%
1 762
+10%
2 068
+17%
1 540
-26%
1 980
+29%
Liabilities
Accounts Payable
18
22
20
29
33
58
70
65
181
92
Accrued Liabilities
11
25
30
32
35
36
101
85
0
85
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
5
0
3
3
0
8
14
15
15
17
Other Current Liabilities
43
25
34
9
46
94
170
170
0
91
Total Current Liabilities
77
71
88
74
114
195
355
334
195
285
Long-Term Debt
267
313
329
133
0
78
116
773
509
103
Other Liabilities
0
0
0
0
0
84
61
33
19
0
Total Liabilities
344
N/A
384
+12%
416
+8%
207
-50%
114
-45%
357
+214%
533
+49%
1 140
+114%
724
-36%
387
-47%
Equity
Common Stock
23
24
26
31
31
36
40
44
52
59
Retained Earnings
230
1 035
1 189
1 475
894
1 444
2 290
3 308
750
4 895
Additional Paid In Capital
0
1 263
1 441
1 959
1 979
2 650
3 471
4 250
0
6 406
Treasury Stock
0
0
0
0
0
0
0
72
0
0
Other Equity
0
0
0
0
0
0
9
14
15
23
Total Equity
253
N/A
252
0%
278
+10%
515
+85%
1 116
+117%
1 243
+11%
1 229
-1%
928
-25%
816
-12%
1 593
+95%
Total Liabilities & Equity
597
N/A
636
+7%
695
+9%
721
+4%
1 230
+71%
1 600
+30%
1 762
+10%
2 068
+17%
1 540
-26%
1 980
+29%
Shares Outstanding
Common Shares Outstanding
23
24
26
28
31
36
40
43
51
58

See Also

Discover More